Rifampicin News and Research

RSS
New rapid tests for drug-resistant TB for developing countries

New rapid tests for drug-resistant TB for developing countries

Increasing transmission of drug resistant tuberculosis in the UK

Increasing transmission of drug resistant tuberculosis in the UK

Hard to treat TB case diagnosed in Britain

Hard to treat TB case diagnosed in Britain

WHO ready to tackle drug resistant TB

WHO ready to tackle drug resistant TB

New plan to contain extensively drug-resistant TB (XDR-TB)

New plan to contain extensively drug-resistant TB (XDR-TB)

Extremely drug resistant TB a serious problem in India

Extremely drug resistant TB a serious problem in India

Patient adherence an essential factor for successful tuberculosis treatment

Patient adherence an essential factor for successful tuberculosis treatment

XDR-TB in South Africa

XDR-TB in South Africa

Measures to combat XDR-TB worldwide

Measures to combat XDR-TB worldwide

Extensive Drug Resistant TB now a major threat

Extensive Drug Resistant TB now a major threat

Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia

Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia

New combination treatment that could dramatically shorten the length of tuberculosis treatment

New combination treatment that could dramatically shorten the length of tuberculosis treatment

Hospital "super super bug" stronger than MRSA

Hospital "super super bug" stronger than MRSA

Inexpensive treatment stops multi-drug resistant TB in its tracks

Inexpensive treatment stops multi-drug resistant TB in its tracks

Rifampicin can prevent the formation of protein fibrils associated with Parkinson's disease

Rifampicin can prevent the formation of protein fibrils associated with Parkinson's disease

WHO reports on treating tuberculosis in Ukraine

WHO reports on treating tuberculosis in Ukraine